Halozyme Therapeutics shares owned by Linden Advisors
Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Linden Advisors
from 13F filings
Historical chart of Linden Advisors investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Linden Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Linden Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $53B | 63M | 847.44 |
| 2023-06-30 | $48B | 57M | 833.17 |
| 2023-03-31 | $9.4M | 11M | 0.85 |
| 2022-12-31 | $2.4M | 2.5M | 0.97 |